Catalyst Wire Dossier Catalyst Wire Dossier

BT-2

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BT-2, covering 2025-11-20 to 2025-11-20. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial to Evaluate the Efficacy and Safety of DA-2811 When Added to Ongoing BT-1 and BT-2 Combination Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control [Phase 2]

See pricing